Advocacy & Public Policy
Resources from the 黑料正能量 Association (AHA) on advocacy and public policy health care issues.
On behalf of nearly 5,000 member hospitals, health systems and other health care organizations, clinical partners, and the 43,000 health care leaders who belong to our professional membership groups, the 黑料正能量 Association (AHA) writes House leaders regarding funding for health care鈥
We call on Congress to act now to make the American Rescue Plan Act of 2021 (ARPA) expanded access to the ACA鈥檚 advanced premium tax credits (APTCs) permanent, ensuring millions of low- and middle-income families continue to have access to affordable coverage in 2023 and beyond.
Courage. Compassion. Workforce. Health equity. Heroes. Challenges. Innovation. Community partnerships. Leadership. Opportunities. These were some of the most common words we heard from attendees and speakers talking about our field at this week鈥檚 AHA Annual Membership Meeting in Washington, D.C.
The Centers for Medicare & Medicaid Services Friday released a proposed rule that would implement provisions in the Consolidated Appropriations Act of 2021 that revise the effective dates of coverage in traditional Medicare; authorize special enrollment periods for certain eligible鈥
AHA Friday voiced support for a Department of Homeland Security proposal to exclude noncash benefits, such as the Children鈥檚 Health Insurance Program and most Medicaid benefits, when making a public charge inadmissibility determination for noncitizens requesting admission to the United States鈥
A new AHA report highlights the significant growth in expenses across labor, drugs, and supplies, as well as the impact that rising inflation is having on hospital prices.
Visit the Apple App Store or Google Play store and search for 鈥満诹险芰 Association.鈥 Locate and select the member app, titled My AHA Connect.
AHA voiced support for H. Res. 909, which condemns violence against health care workers and expresses support for health care personnel.
In a statement submitted to the Senate Finance Committee for a hearing on lowering drug prices in Medicare, AHA encouraged Congress to implement policies that would increase generic alternatives and discourage anti-competitive tactics while maintaining incentives to develop innovative new therapies鈥